Trevi Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New Haven, CT
SEC filing record 1 source field available
Fiscal year end
31 December
Trevi Therapeutics, Inc. has filed 534 SEC EDGAR filings since 18 Dec 2012

SEC filing history

Showing 251-275 of 534 matching filings.

Per page
25
Current page
11
4/A

FORM 4/A SUBMISSION

Filing date
01 Jul 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

CHANGES IN BENEFICIAL OWNERSHIP

Filing date
01 Jul 2022
Reporting date
29 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-239499

424B5

Filing date
16 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-264614

EFFECT filing

Filing date
11 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
06 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 May 2022
Reporting date
02 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

CHANGES IN BENEFICIAL OWNERSHIP

Filing date
02 May 2022
Reporting date
28 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-264615

S-8

Filing date
02 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-264614

S-3

Filing date
02 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38886

DEFA14A

Filing date
02 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38886

DEF 14A

Filing date
29 Apr 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91005

NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A3

Filing date
25 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91005

SC 13G

Filing date
21 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .